Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0PQ5T
|
|||
| Former ID |
DNC002335
|
|||
| Drug Name |
Azelaic bishydroxamic acid
|
|||
| Synonyms |
Azelaic bishydroxamic acid; 18992-11-5; Azelaic bis(hydroxamic acid); Nonanedihydroximic acid; N,N'-dihydroxynonanediamide; Azelaic bis hydroxamic acid; AC1L22XV; SCHEMBL4741072; CHEMBL495390; Nonanediamide, N,N'-dihydroxy-; DTXSID30172421; ZINC5178518; NSC611775
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C9H18N2O4
|
|||
| Canonical SMILES |
C(CCCC(=O)NO)CCCC(=O)NO
|
|||
| InChI |
1S/C9H18N2O4/c12-8(10-14)6-4-2-1-3-5-7-9(13)11-15/h14-15H,1-7H2,(H,10,12)(H,11,13)
|
|||
| InChIKey |
VBJZDMOTYJEHEP-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 18992-11-5
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Histone deacetylase (HDAC) | Target Info | Inhibitor | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov. 2006 Sep;5(9):769-84. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.